ADC Therapeutics SA ADCT

$ 1.97 -7.31%

Annual report 2022
added 12-21-2024

ADC Therapeutics SA Balance Sheet 2011-2024 | ADCT

Annual Balance Sheet ADC Therapeutics SA

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-459 M	-330 M	-	-	-263 M	-144 M	-	-	-	-	-
Long Term Debt	-	6.99 M	108 M	-	-	-	-	-	-	-	-	-
Long Term Debt Current	1.1 M	1.03 M	1 M	924 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	378 M	138 M	-	1.96 M	2.24 M	4.52 M	-	-	-	-	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	440 M	452 M	178 M	26.5 M	24.3 M	22.8 M	14.2 M	-	-	-	-	-
Deferred Revenue	-	-	-	834 K	1.76 M	2.32 M	1.84 M	-	-	-	-	-
Retained Earnings	-	-925 M	-695 M	-449 M	-332 M	-209 M	-119 M	-	-	-	-	-
Total Assets	529 M	618 M	514 M	138 M	151 M	272 M	155 M	-	-	-	-	-
Cash and Cash Equivalents	326 M	467 M	439 M	116 M	139 M	-	-	-	-	-	-	-
Book Value	88.7 M	166 M	336 M	111 M	126 M	249 M	141 M	-	-	-	-	-
Total Shareholders Equity	-	166 M	336 M	111 M	126 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet ADC Therapeutics SA

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	6.61 M	6.99 M	7.18 M	7.61 M	7.6 M	2.46 M	2.6 M	3.33 M	3.56 M	4.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	348 M	378 M	391 M	169 M	122 M	138 M	-	-	-	6.58 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	419 M	452 M	451 M	220 M	164 M	178 M	-	-	-	26.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-942 M	-925 M	-891 M	-819 M	-746 M	-695 M	-	-	-	-449 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	582 M	618 M	638 M	464 M	462 M	514 M	-	-	-	138 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	431 M	467 M	530 M	372 M	383 M	439 M	494 M	349 M	82.6 M	116 M	-	-	-	139 M	-	-	-	263 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	163 M	166 M	187 M	244 M	298 M	336 M	-	-	-	111 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	163 M	166 M	187 M	244 M	298 M	336 M	376 M	196 M	71.3 M	111 M	-	-	-	126 M	-	-	-	249 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency